Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)

Author： Nagalakshmi K. Jamil Kaiser Pingali Usharani Reddy M. Vishnuvardhan Attili Suresh S. V.

ISSN： 1366-5804

Source： Biomarkers, Vol.19, Iss.3, 2014-05, pp. : 198-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)

FEBS Open Bio, Vol. 4, Iss. 1, 2014-01 ,pp. : 96-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer

By Herbst Roy S Kim Edward S Harari Paul M

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 719-732

Informa Healthcare

Access to resources Recommend Favorite

Novel Agents Targeting Crucial Signalling Pathways in Head and Neck Squamous Cell Carcinoma, HNSCC - Preclinical Development and Data from Clinical Trials

Current Proteomics, Vol. 10, Iss. 2, 2013-07 ,pp. : 150-164

Bentham Science Publishers

Access to resources Recommend Favorite

The Nuclear Accumulation of a Variant Epidermal Growth Factor Receptor (EGFR) Lacking the Transmembrane Domain Requires Coexpression of a Full-Length EGFR

By Marti U. Wells A.

Molecular Cell Biology Research Communications, Vol. 3, Iss. 1, 2000-01 ,pp. : 8-14

Academic Press

Access to resources Recommend Favorite

Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma

By Chiu Tai-Jan Chen Yi-Ju Rau Kun-Ming Chen Chang-Han Chien Chih-Yen Li Shau-Hsuan Tsai Hsin-Ting Eng Hock-Liew

Biomarkers, Vol. 18, Iss. 8, 2013-12 ,pp. : 687-698

Informa Healthcare

Access to resources Recommend Favorite